<- Go Home
Eucrates Biomedical Acquisition Corp.
Eucrates Biomedical Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. Eucrates Biomedical Acquisition Corp. was incorporated in 2020 and is based in New York, New York.
Market Cap
$42.2M
Volume
17.3K
Cash and Equivalents
$18.9K
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$10.25
52 Week Low
$9.87
Dividend
N/A
Price / Book Value
-11.36
Price / Earnings
48.36
Price / Tangible Book Value
-11.36
Enterprise Value
$42.3M
Enterprise Value / EBITDA
N/A
Operating Income
N/A
Return on Equity
52.56%
Return on Assets
N/A
Cash and Short Term Investments
$18.9K
Debt
$60.1K
Equity
-$3.7M
Revenue
N/A
Unlevered FCF
N/A
Sector
Capital Markets
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium